![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, September 21, 2015 8:27:31 PM
Alf-x is a direct competitor to isrg da Vinci. Surgibot is still on track for fda approval in Q1 2016.
By the time Titan has one product on the market, TRXC is going to have a single port and a multi port system on the market already selling for 1.5 years. Titxf is in dead last and today's news solidifies it.
But hey, I guess TiTXF deserves a fair value of $100M when compared to the alf-x valuation. So $1.00 per share seems to be fair for TITXF
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM